CLEARPOINT NEURO INC (CLPT)

Company Profile

Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The company is headquartered in Solana Beach, California and currently employs 107 full-time employees. The company went IPO on 2019-07-03. The firm provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. The Company’s flagship product is the ClearPoint Neuro Navigation System. Its initial product offering, the ClearPoint system, is an integrated system comprised of capital equipment and disposable products, designed to allow minimally invasive procedures in the brain to be performed in a magnetic resonance imaging (MRI) suite. The ClearPoint Array Neuro Navigation System and its principal disposable component is designed to be deployed in an operating room setting while also being usable in an MRI suite. The company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. The company also provides solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide.

Company Info

CLEARPOINT NEURO INC

120 S. Sierra Avenue, Suite 100

Solana Beach CALIFORNIA 92618

P: 19499006833

CEO: Joseph M. Burnett

Employees: 107

Website: https://www.clearpointneuro.com/